153 related articles for article (PubMed ID: 9547001)
1. Laminin blocks the assembly of wild-type A beta and the Dutch variant peptide into Alzheimer's fibrils.
Bronfman FC; Alvarez A; Morgan C; Inestrosa NC
Amyloid; 1998 Mar; 5(1):16-23. PubMed ID: 9547001
[TBL] [Abstract][Full Text] [Related]
2. Laminin inhibition of beta-amyloid protein (Abeta) fibrillogenesis and identification of an Abeta binding site localized to the globular domain repeats on the laminin a chain.
Castillo GM; Lukito W; Peskind E; Raskind M; Kirschner DA; Yee AG; Snow AD
J Neurosci Res; 2000 Nov; 62(3):451-62. PubMed ID: 11054814
[TBL] [Abstract][Full Text] [Related]
3. Vitamin E but not 17beta-estradiol protects against vascular toxicity induced by beta-amyloid wild type and the Dutch amyloid variant.
Muñoz FJ; Opazo C; Gil-Gómez G; Tapia G; Fernández V; Valverde MA; Inestrosa NC
J Neurosci; 2002 Apr; 22(8):3081-9. PubMed ID: 11943811
[TBL] [Abstract][Full Text] [Related]
4. Laminin inhibits A beta 40 fibril formation promoted by apolipoprotein E4 in vitro.
Monji A; Tashiro K; Yoshida I; Hayashi Y; Tashiro N
Brain Res; 1998 Jun; 796(1-2):171-5. PubMed ID: 9689467
[TBL] [Abstract][Full Text] [Related]
5. Comparative fibril formation of analogs corresponding to the (12-24) segment of the β-amyloid peptide.
Malavolta L; Nakaie CR
Neurol Sci; 2011 Dec; 32(6):1123-7. PubMed ID: 21904866
[TBL] [Abstract][Full Text] [Related]
6. Laminin inhibits Abeta42 fibril formation in vitro.
Monji A; Tashiro K; Yoshida I; Tashiro N
Brain Res; 1998 Mar; 788(1-2):187-90. PubMed ID: 9555007
[TBL] [Abstract][Full Text] [Related]
7. Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide.
Cottingham MG; Hollinshead MS; Vaux DJ
Biochemistry; 2002 Nov; 41(46):13539-47. PubMed ID: 12427014
[TBL] [Abstract][Full Text] [Related]
8. Pathologic amyloid beta-protein cell surface fibril assembly on cultured human cerebrovascular smooth muscle cells.
Van Nostrand WE; Melchor JP; Ruffini L
J Neurochem; 1998 Jan; 70(1):216-23. PubMed ID: 9422365
[TBL] [Abstract][Full Text] [Related]
9. Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability.
Castillo GM; Ngo C; Cummings J; Wight TN; Snow AD
J Neurochem; 1997 Dec; 69(6):2452-65. PubMed ID: 9375678
[TBL] [Abstract][Full Text] [Related]
10. Unique molecular signatures of Alzheimer's disease amyloid β peptide mutations and deletion during aggregate/oligomer/fibril formation.
Poduslo JF; Howell KG
J Neurosci Res; 2015 Mar; 93(3):410-23. PubMed ID: 25377128
[TBL] [Abstract][Full Text] [Related]
11. Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils.
Alvarez A; Opazo C; Alarcón R; Garrido J; Inestrosa NC
J Mol Biol; 1997 Sep; 272(3):348-61. PubMed ID: 9325095
[TBL] [Abstract][Full Text] [Related]
12. Direct evidence for self-propagation of different amyloid-β fibril conformations.
Spirig T; Ovchinnikova O; Vagt T; Glockshuber R
Neurodegener Dis; 2014; 14(3):151-9. PubMed ID: 25300967
[TBL] [Abstract][Full Text] [Related]
13. Laminin inhibits amyloid-beta-peptide fibrillation.
Bronfman FC; Garrido J; Alvarez A; Morgan C; Inestrosa NC
Neurosci Lett; 1996 Nov; 218(3):201-3. PubMed ID: 8945763
[TBL] [Abstract][Full Text] [Related]
14. In vitro oligomerization and fibrillogenesis of amyloid-beta peptides.
Benseny-Cases N; Klementieva O; Cladera J
Subcell Biochem; 2012; 65():53-74. PubMed ID: 23224999
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential for amyloid surface inhibitor: only amyloid-β oligomers formed by secondary nucleation disrupt lipid membrane integrity.
Tian Y; Liu J; Yang F; Lian C; Zhang H; Viles JH; Li Z
FEBS J; 2022 Nov; 289(21):6767-6781. PubMed ID: 35670622
[TBL] [Abstract][Full Text] [Related]
16. Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme.
Inestrosa NC; Alvarez A; Pérez CA; Moreno RD; Vicente M; Linker C; Casanueva OI; Soto C; Garrido J
Neuron; 1996 Apr; 16(4):881-91. PubMed ID: 8608006
[TBL] [Abstract][Full Text] [Related]
17. Anthocyanin suppresses the toxicity of Aβ deposits through diversion of molecular forms in in vitro and in vivo models of Alzheimer's disease.
Yamakawa MY; Uchino K; Watanabe Y; Adachi T; Nakanishi M; Ichino H; Hongo K; Mizobata T; Kobayashi S; Nakashima K; Kawata Y
Nutr Neurosci; 2016; 19(1):32-42. PubMed ID: 26304685
[TBL] [Abstract][Full Text] [Related]
18. Brain acetylcholinesterase promotes amyloid-beta-peptide aggregation but does not hydrolyze amyloid precursor protein peptides.
Campos EO; Alvarez A; Inestrosa NC
Neurochem Res; 1998 Feb; 23(2):135-40. PubMed ID: 9475506
[TBL] [Abstract][Full Text] [Related]
19. Lipid membranes catalyse the fibril formation of the amyloid-β (1-42) peptide through lipid-fibril interactions that reinforce secondary pathways.
Lindberg DJ; Wesén E; Björkeroth J; Rocha S; Esbjörner EK
Biochim Biophys Acta Biomembr; 2017 Oct; 1859(10):1921-1929. PubMed ID: 28564579
[TBL] [Abstract][Full Text] [Related]
20. Laminin inhibits both Abeta40 and Abeta42 fibril formation but does not affect Abeta40 or Abeta42-induced cytotoxicity in PC12 cells.
Monji A; Tashiro K; Yoshida I; Kaname H; Hayashi Y; Matsuda K; Tashiro N
Neurosci Lett; 1999 May; 266(2):85-8. PubMed ID: 10353333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
